Michael Halstead - Net Worth and Insider Trading

Michael Halstead Net Worth

The estimated net worth of Michael Halstead is at least $0 dollars as of 2024-11-06. Michael Halstead is the EVP and General Counsel of Intra-Cellular Therapies Inc and owns about 0 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $0. Details can be seen in Michael Halstead's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Halstead has not made any transactions after 2024-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Halstead

To

Michael Halstead Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Halstead owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .

Click here to see the complete history of Michael Halstead’s form 4 insider trades.

Insider Ownership Summary of Michael Halstead

Ticker Comapny Transaction Date Type of Owner
ITCI Intra-Cellular Therapies Inc 2024-03-11 SVP and General Counsel

Michael Halstead Latest Holdings Summary

Michael Halstead currently owns a total of 1 stock. Michael Halstead owns 0 shares of Intra-Cellular Therapies Inc (ITCI) as of March 11, 2024, with a value of $0.

Latest Holdings of Michael Halstead

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITCI Intra-Cellular Therapies Inc 2024-03-11 0 89.24 0

Holding Weightings of Michael Halstead


Michael Halstead Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Halstead has made a total of 20 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 20,477 shares on March 11, 2024, which brought Michael Halstead around $1 Million.

Insider Trading History of Michael Halstead

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Halstead Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Halstead Ownership Network

Ownership Network List of Michael Halstead

No Data

Ownership Network Relation of Michael Halstead

Insider Network Chart

Michael Halstead Owned Company Details

What does Intra-Cellular Therapies Inc do?

Who are the key executives at Intra-Cellular Therapies Inc?

Michael Halstead is the SVP and General Counsel of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , EVP & Chief Commercial Officer Mark Neumann , and Chief Medical Officer Suresh K. Durgam .

Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary

Over the past 18 months, Michael Halstead made 5 insider transaction in Intra-Cellular Therapies Inc (ITCI) with a net sale of 140,244. Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 696,112 shares made by Sharon Mates , a net sale of 156,651 shares made by Mark Neumann , and a net sale of 105,827 shares made by Suresh K. Durgam .

In summary, during the past 3 months, insiders sold 305,712 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 305,712 shares. During the past 18 months, 1,299,251 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,299,251 shares.

Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intra-Cellular Therapies Inc Insider Transactions

No Available Data

Michael Halstead Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Halstead. You might contact Michael Halstead via mailing address: C/o Warner Chilcott Corporation, 100 Enterprise Drive, Rockaway Nj 07866.